Inverkeithing-based Epipole has secured £1.5 million in funding to market its ground-breaking video retinal imaging device in the US.

 

The funding was led by new investor Greenwood Way Capital with the Scottish Investment Bank, the investment arm of Scottish Enterprise, also participating.

 

Epipole’s patented technology enables clinicians to scan the retina using real-time video and then extract high quality images for further examination.  These images are smaller and less expensive than those produced by conventional desktop systems.

 

Read more.

 

Click for more information about the Scottish Investment Bank and how it could support your business.

This entry was posted in . Bookmark the permalink.